The standard research protocol is 300 mcg per day, subcutaneous, administered in a fasted state, typically in the morning before food or exercise
The most commonly reported events in active arms were mild and transient: injection site reactions in some subcutaneous subjects, occasional headache, and in some oral dosing arms, minor gastrointestinal tolerance issues
Labs that buy AHK-Cu typically use it across a handful of recurring research applications: A Brief History of Copper Peptide Research Copper peptides entered scientific literature in the late 1970s and early 1980s, when researchers first isolated a naturally occurring copper-binding tripeptide from human plasma and began studying its role in wound healing
One point specific to a metal complex: the mass includes the copper and any counterion, so a molar figure calculated from the complex mass is not the same as one calculated from the free peptide mass, and the two are commonly confused
CAS Number: 767286-83-9
They are not approved for human or veterinary use